Holen Sie sich die Stockscreener-App
0.2844
26.96%
0.0604
Handel nachbörslich:
.26
-0.0244
-8.58%
Ispecimen Inc Aktie (ISPC) Neueste Nachrichten
iSpecimen Faces Ongoing Shareholder Quorum Challenges for Meeting - TipRanks
iSpecimen annual meeting adjourned again due to lack of quorum - Investing.com UK
Stocks Under $1: TOON, ISPC, CXAI, EONR to Watch Now - Barchart.com
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Dow Gains Over 300 Points; US GDP Growth Revised Lower In Q4 - Benzinga
ISPC: No quorum was present, so the meeting was adjourned without any business or voting - TradingView
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Why Is iSpecimen Stock (ISPC) Up Today 3/13/26? - TipRanks
Why Oncology Institute Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket - Benzinga
iSpecimen (ISPC) Stock Rockets 43% After Hours — Here's Why It's Trending - Benzinga
New AI tool aims to speed scientists' access to human biospecimens - Stock Titan
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
iSpecimen Launches AI Agent Revolutionizing Biospecimen Matching - Bluefield Daily Telegraph
ISpecimen Inc. Launches AI-Powered Inventory Agent - marketscreener.com
Levels Update: Will iSpecimen Inc. stock continue dividend increasesJuly 2025 Spike Watch & High Accuracy Swing Entry Alerts - Naître et grandir
Market Recap: Will iSpecimen Inc stock go up in YEAREarnings Overview Summary & Weekly Stock Performance Updates - baoquankhu1.vn
iSpecimen (ISPC) Expected to Announce Quarterly Earnings on Thursday - Defense World
ISPC SEC FilingsIspecimen Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
ISPC Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
iSpecimen (ISPC) Pops on Nano Antibody News: Can The Rally Last? - AD HOC NEWS
ISPC Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Aug Ideas: Is iSpecimen Inc stock overvalued or fairly pricedRate Hike & High Accuracy Investment Entry Signals - baoquankhu1.vn
Director Siyun Yang leaves iSpecimen (NASDAQ: ISPC) board role - Stock Titan
Ispecimen Inc. Announces Resignation of Independent Director Siyun Yang, Effective February 17, 2026 - marketscreener.com
Pullback Watch: Is Marine Petroleum Trust stock a falling knife or bargain buyWeekly Risk Summary & Weekly Setup with ROI Potential - baoquankhu1.vn
iSpecimen Faces Ongoing Annual Meeting Quorum Challenges - TipRanks
iSpecimen to Reconvene 2025 Annual Meeting Again on March 13 After Multiple Adjournments - TradingView
Will iSpecimen Inc. benefit from sector rotation2025 Sector Review & Daily Growth Stock Tips - mfd.ru
Is iSpecimen Inc. part of any major indexEarnings Risk Report & Growth Focused Stock Pick Reports - mfd.ru
Can iSpecimen Inc. sustain its profitabilityJuly 2025 Analyst Calls & Risk Controlled Swing Alerts - mfd.ru
ISPC PE Ratio & Valuation, Is ISPC Overvalued - Intellectia AI
Insider Buy: Is BCSAW stock trending bullishJuly 2025 Volume & Low Drawdown Investment Strategies - baoquankhu1.vn
Is iSpecimen Inc. forming a double bottom2025 Volume Leaders & Growth-Oriented Investment Plans - mfd.ru
Buyback Watch: Is iSpecimen Inc stock overvalued or fairly priced2025 Key Lessons & Intraday High Probability Alerts - baoquankhu1.vn
Market Review: Is iSpecimen Inc subject to activist investor interest2025 Pullback Review & Consistent Income Trade Recommendations - baoquankhu1.vn
Aug Levels: How does Mesa Royalty Trust compare to its peersGap Down & Daily Volume Surge Signals - baoquankhu1.vn
iSpecimen Advances Digital Marketplace with SalesStack Milestone - The Globe and Mail
iSpecimen Achieves Rapid Procurement Milestone for Influenza Research - The Globe and Mail
iSpecimen Announces Milestone 2: System Integration and Marketplace Activation Complete - The Globe and Mail
Aug Spikes: Will iSpecimen Inc stock go up in YEARWeekly Stock Summary & Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
iSpecimen completes milestone in SalesStack digital transformation By Investing.com - Investing.com South Africa
iSpecimen Inc Completes Milestone 2 and Achieves Rapid Procurement for Influenza Research - TradingView
iSpecimen completes milestone in SalesStack digital transformation - Investing.com
ISpecimen Announces Milestone 2: System Integration and Marketplace Activation Complete - marketscreener.com
Aug Opening: What are the future prospects of iSpecimen Inc2025 Sector Review & Verified Momentum Stock Alerts - baoquankhu1.vn
iSpecimen Announces Milestone 2: System Integration and Marketplace Activation Complete | ISPC Stock News - Longbridge
What are the future prospects of iSpecimen IncWeekly Market Summary & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Panic Selling: Will iSpecimen Inc benefit from sector rotationWeekly Market Outlook & Weekly Top Stock Performers List - baoquankhu1.vn
ISpecimen announces pricing of $5.5M private placement - MSN
iSpecimen plans $200M Solana-based digital asset treasury - MSN
iSpecimen Reschedules 2025 Annual Meeting Amid Quorum Issues - The Globe and Mail
iSpecimen Inc. Adjourns Annual Meeting Due to Lack of Quorum - TradingView
iSpecimen raises capital via new series C preferred - MSN
ISPC: No quorum was present, so the annual meeting was adjourned without conducting business - TradingView
Aug Movers: Whats the fair value of iSpecimen Inc stockWeekly Trade Summary & Free Community Supported Trade Ideas - baoquankhu1.vn
Trade Recap: What is the earnings history of Yum Brands IncEarnings Growth Report & Safe Entry Point Identification - baoquankhu1.vn
Breakout Zone: How does iSpecimen Inc compare to its peersEntry Point & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
Why iSpecimen Inc. stock could be next big winner2025 Fundamental Recap & Real-Time Volume Triggers - Bollywood Helpline
Stock Market Recap: Whats the fair value of iSpecimen Inc stockJuly 2025 Summary & Long-Term Growth Plans - baoquankhu1.vn
0.34%
0.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):